To date, a wide range of sphingosine, amidine, bicyclic aryl, amino-alcohol-based, and lipidic and non-lipidic small molecule SPHK inhibitors have been designed and applied in the areas of cancer, allergy and inflammation, transplantation, and viral infection treatment [35]. Here, SPHK1 is linked to viral infectious disease.